ReviewCells2024

The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease Progression.

Rafael Franco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.